DUBLIN--(BUSINESS WIRE)--The "Middle East Dermal Fillers Market by Type, by Application, by End User, by Geography -Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023" report has been added to ResearchAndMarkets.com's offering.
The growth is mainly led by increasing prevalence of skin problems, growing aging population, increasing awareness about age related skin problems, thriving medical tourism industry, and increase in disposable income.
On the basis of the type of dermal fillers, the market is categorized into hyaluronic acid-based, hydroxylapatite-based, synthetic polymer-based, and collagen-based fillers. Till now, hyaluronic acid-based fillers have been accounting for the largest share in the dermal fillers market of the Middle East. It is also expected to be the fastest growing category during the forecast period. This can be mainly attributed to the ability of these tissue fillers to attract water molecules, which aids in hydration and increasing skin volume.
On the basis of application, the dermal fillers market in the Middle East has been segmented into facial line correction, face lift, lip treatment, and others. Facial line correction has been holding the largest share in the dermal fillers market, with an estimated revenue contribution of 45.6% in 2017. It is also expected to be the fastest growing category during the forecast period, due to increasing number of patients opting for this treatment.
Dermal fillers are used by various end-users, such as dermatology clinics, hospitals, and others. Among these, dermatology clinics is the largest end user of tissue fillers in the Middle East and it is also expected to be the fastest growing end user category during the forecast period, owing to the presence of skilled professionals in these clinics for administering these fillers.
- Saudi Arabia to remain the largest market in the Middle East for dermal fillers
- Key players launching hyaluronic acid-based fillers in the Middle East market
- Allergan plc
- Galderma S.A.
- Merz Pharma GmbH & Co. KGaA
- Sinclair Pharma plc
- Teoxane Laboratories
For more information about this report visit https://www.researchandmarkets.com/research/zzvrww/middle_east?w=4